NCT04333134View on ClinicalTrials.gov

A Trial of SHR3162 in Healthy Caucasian Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 17, 2020

Primary Completion Date

May 15, 2020

Study Completion Date

June 30, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

SHR3162

Fluzoparib, also known as SHR3162, is an inhibitor of human PARP

Trial Locations (1)

2000

Atridia Pty Limited, Sydney

All Listed Sponsors
lead

Atridia Pty Ltd.

INDUSTRY

NCT04333134 - A Trial of SHR3162 in Healthy Caucasian Volunteers | Biotech Hunter | Biotech Hunter